Drug ID: | NPD7979 |
Drug Name: | |
Molecular Formula: | C35H56N6O5 |
Canonical SMILES: | CN[C@H](C(=O)N1CCC[C@H]1C(=O)N(C(=O)[C@H](C(C)C)N=C([C@@H](N(C)C)C(C)C)O)C(=O)[C@@H]1CCCN1Cc1ccccc1)C(C)C |
Standard InCHI: | InChI=1S/C35H56N6O5/c1-22(2)28(36-7)34(45)40-20-14-18-27(40)33(44)41(32(43)26-17-13-19-39(26)21-25-15-11-10-12-16-25)35(46)29(23(3)4)37-31(42)30(24(5)6)38(8)9/h10-12,15-16,22-24,26-30,36H,13-14,17-21H2,1-9H3,(H,37,42)/t26-,27-,28-,29-,30-/m0/s1 |
Standard InCHIKey: | LSIZJZZMXCWHBR-IIZANFQQSA-N |
Max Developmental Stage: | Clinical (unspecified phase) |
Max Developmental Stage Source: | TTD |
Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient
Tanimoto coefficient is calculated based on PubChem 881-bit substructure fingerprints.
High Similarity Level: Tc>=0.85; Intermediate Similarity Level: 0.7 <= Tc < 0.85; Remote Similarity Level: 0.65 <= Tc < 0.7